Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

The cannabis producer is entering a new market.

Why Tilray Stock Is Rising Today

Apple

Carnival

SNDL Inc.

One of the most common questions traders have about stocks is “Why Is It Moving?” That's why Benzinga created the Why Is It Moving, or WIIM, feature in Benzinga Pro.

Is Now The Time To Buy Stock In Sundial Growers, Tilray, Apple Or Carnival?

NANAIMO, British Columbia--(BUSINESS WIRE)--Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced that it has received the necessary approvals from New Zealand's Ministry of Health and the Medicinal Cannabis Agency to launch Tilray medical cannabis products across the country. Tilray is one of the leading providers of medical cannabis in Australia and New Zealand for commercial, compassionate access, and research purposes

Tilray® Receives Approvals to Expand and Commercialize Medical Cannabis Products in New Zealand

Aphria

Canopy Growth

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Trulieve Cannabis Corp.

Alpha Trader Talks Cannabis Investing With Todd Harrison (Podcast)

Investors in TLRY stock have been on a very turbulant ride of late, and it's likely that this volatility will continue for some time. The post Tilray Could Have Much More Downside on the Horizon appeared first on InvestorPlace.

Tilray Could Have Much More Downside on the Horizon

It's not the worst idea to invest in the world's largest marijuana grower by revenue.

Is Tilray Stock a Buy?

Aurora Cannabis

Cronos Group

Cannabis growers and distributors dropped for a second straight week, falling with the broader market and on increased concerns about partisan sniping.

Cannabis stocks slump for second straight week as prospects dim for nationwide legalization

Pot stocks like CGC, TLRY, APHA and SNDL stock are down today as investors shift risk preferences and eye inflation rates. The post CGC, TLRY, APHA and SNDL: Why Are Pot Stocks Down Today?

CGC, TLRY, APHA and SNDL: Why Are Pot Stocks Down Today?

GW Pharmaceuticals

Innovative Industrial Properties

Jazz Pharmaceuticals

Global X Cannabis ETF

Village Farms International

AdvisorShares Pure Cannabis ETF 

After soaring to all-time highs last month, exchange traded funds tracking cannabis stocks are coming back down to test a key support line. The post Don't Miss These 2 Ways To Play The Hot Marijuana Stocks Industry appeared first on Investor's Business Daily.

Don't Miss These 2 Ways To Play The Hot Marijuana Stocks Industry

HEXO Corp

OrganiGram Holdings Inc.

Marijuana stocks have been up and down for several years and still seek firm footing. Right now, these seven aren't worth your money.

7 Marijuana Stocks That Look Way Too Expensive Here

The merger between Tilray and Aphria should drive higher revenue and better margins. But the premium assigned TLRY stock means investors should go another route.

If You Like the Tilray Merger, Don't Buy Tilray Stock

Investors are salivating at the prospect of greater market access over the next few quarters.

Why Tilray Stock Rose 35% in February

After the merger with Aphria is finalized, TLRY stock holders will own a small piece of the biggest cannabis company on the planet. The post Play a Game of ‘Pot Monopoly' with Tilray Stock appeared first on InvestorPlace.

Play a Game of ‘Pot Monopoly' with Tilray Stock

Marijuana will provide the basis for many of tomorrow's blockbuster drugs. David Borun shows you how to invest in this burgeoning industry.

Investors: The Marijuana Boom Is Now

But is that enough of a reason to invest in the company?

Tilray Beats Canopy Growth and Aurora Cannabis to Profitability

MedMen Enterprises Inc.

Each of these cannabis stocks blazed higher by between 20% and 208% last month.

The 10 Best Marijuana Stocks in February

There are a few things to consider first.

Should You Buy Tilray Stock Before the Aphria Merger?

Cannabis stocks are soaring once again on some pretty bullish news coming out of Virginia, stoking federal legalization expectations. The post Cannabis Stocks: Why SNDL, APHA, TLRY and CGC Are Gaining Today appeared first on InvestorPlace.

Cannabis Stocks: Why SNDL, APHA, TLRY and CGC Are Gaining Today

Clever Leaves Holdings Inc

Marijuana stocks are volatile right now. Cut through the noise with this ranking of seven leaders from best to worst.

Ranking the Top 7 Marijuana Stocks From Best to Worst

Could marijuana become federally legal within the next year?

Ahead of Merger, Tilray and Aphria CEOs Are Optimistic About Cannabis Legalization

Should You Buy These Hot Cannabis Stocks Before It's Too Late?

End-to-end value cannabis stocks operating in Canada are flying high, but a retracement to near fair value is imminent. The cannabis industry is changing due to vertical integration being scrapped and an influx of competitors.

Canadian End-To-End Value Cannabis Stocks Present Opportunities For Short Sellers

Top marijuana stocks rose as Virginia lawmakers on Saturday approved legislation that would legalize recreational use of cannabis by 2024. The post Marijuana Stocks Surge As First Southern State OKs Recreational Use appeared first on Investor's Business Daily.

Marijuana Stocks Surge As First Southern State OKs Recreational Use

Arena Pharmaceuticals

cbdMD Inc

Welcome back to our weekly series, Sc haeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will continue to develop in the 2021.

8 Red-Hot Pot Stocks Toughing Out Last Week's Winter Weather

TLRY stock is already having an amazing 2021, but it's only the beginning. The Tilray-Aphria merger is expected to close in the second quarter of the year.

Tilray Is Gathering Momentum for a Profitable 2021

News for Tilray Brands Stock (TLRY)